Related Experiment Videos
In vitro stem cell assay in head and neck squamous carcinoma
American Journal of Surgery
|October 1, 1980
Summary
The soft agar stem cell assay successfully cultured head and neck squamous cell carcinoma. Higher cloning efficiencies correlated with poorer prognosis and predicted treatment resistance in cancer patients.
Area of Science:
- Oncology
- Cancer Biology
- Cell Culture Techniques
Background:
- Head and neck squamous cell carcinoma (HNSCC) is a significant global health concern.
- Effective prognostic markers and predictive tools for treatment response in HNSCC are crucial.
- The Hamburger and Salmon soft agar technique offers a potential in vitro model for cancer studies.
Purpose of the Study:
- To evaluate the efficacy of the soft agar stem cell assay for culturing HNSCC specimens.
- To correlate in vitro stem cell growth characteristics with clinical outcomes and tumor differentiation.
- To assess the utility of the assay for predicting in vivo chemotherapeutic drug sensitivity.
Main Methods:
- Utilized the Hamburger and Salmon soft agar technique to culture 73 HNSCC specimens.
- Analyzed successful culture rates from primary tumors versus metastases.
- Assessed cloning efficiency across different histologic grades and correlated with patient survival.
- Performed in vitro drug sensitivity testing and compared with in vivo responses.
Main Results:
- Achieved a 45% success rate in culturing HNSCC specimens using soft agar.
- No significant difference in successful culture rates between primary tumors and metastases.
- Higher median cloning efficiency observed in poorly differentiated tumors.
- Cloning efficiency >0.02% was significantly associated with early mortality (p < 0.01).
- In vitro drug sensitivity testing accurately predicted in vivo resistance in three patients.
Conclusions:
- The soft agar stem cell assay is a viable method for culturing HNSCC.
- Tumor stem cell cloning efficiency serves as a prognostic indicator for HNSCC.
- This in vitro assay demonstrates potential as a predictive tool for chemotherapy response in HNSCC patients.
- The assay is a valuable tool for future clinical and biological research in head and neck cancer.